about
Dose finding studies with imidapril--a new ACE inhibitor.Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.Cough associated with captopril and enalaprilCaptopril: 4 years of post marketing surveillance of all patients in New Zealand.Haemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension.Maintenance of the antihypertensive efficacy of captopril despite consistent reduction in daily dosageSustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertensionEffective dose range of enalapril in mild to moderate essential hypertension.Reversible cholestatic jaundice and hyperamylasaemia associated with captopril treatment.Captopril in hypertension after renal transplantation.Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failureThe chemistry of enalapril.Hypertension is a myth.Oral antihypertensives for hypertensive urgencies.Hemolytic anemia: possible complication of captopril therapy.Captopril: five years on.Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts.Changes in arterial distensibility produced by converting enzyme inhibitors in hypertensive humans.The acute haemodynamic effects of captopril in dogs with heart failure.
P2860
Q24538596-659AE500-A1B1-4852-B44A-FD6F9A311796Q34048636-2D113F32-E303-4FF7-85D7-FBBEB923F68FQ34070598-310842AB-CA98-442C-B75A-0599BCF2BAC2Q34416636-B07C4D10-AE47-4A92-8FD0-72A8BC61A210Q34447295-224CB296-7BB6-45CD-B613-FF15957DE3F3Q34511340-89370A99-44D8-4A88-BF1F-1CF986868ACEQ34511390-59702E84-C79D-472A-869E-6D920D7961D6Q34621390-D0C78D4D-DF09-49DD-ACF6-495C363202F7Q34622710-C32C0F19-2D97-41E8-9355-4F2756462EB0Q34996729-FE19CD0D-C2EC-4AA1-9AB8-A357506432F9Q36705052-A907A7DB-E780-41CE-8B10-3CF45A349530Q36745527-9DEA3AE4-E978-44F6-A85B-C5EDA0325F6AQ40076212-100060B6-B437-402B-B2BB-5378CADC526AQ40155219-FB6C0FCB-253B-4FA3-9D33-5DABEBA0A4B6Q40757467-5643980E-C877-432E-9303-66AAB45732DFQ42778084-90E11A81-5493-47A2-AF32-4971BA63940DQ42846196-396E71F0-FB49-455A-9A39-C87ACC909C70Q43228807-FC0630FD-7D10-487B-A14D-9C424BC77045Q44818185-5839693D-1375-4400-A457-F9A89890A411Q46321473-DA5CD94F-9D45-444D-A077-1580F5DCB4B5
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Medical intelligence drug therapy: captopril.
@en
type
label
Medical intelligence drug therapy: captopril.
@en
prefLabel
Medical intelligence drug therapy: captopril.
@en
P2093
P1476
Medical intelligence drug therapy: captopril.
@en
P2093
P304
P356
10.1056/NEJM198201283060405
P407
P577
1982-01-01T00:00:00Z